ECSP003694A - Kit combinado para el tratamiento de la malaria - Google Patents

Kit combinado para el tratamiento de la malaria

Info

Publication number
ECSP003694A
ECSP003694A EC2000003694A ECSP003694A ECSP003694A EC SP003694 A ECSP003694 A EC SP003694A EC 2000003694 A EC2000003694 A EC 2000003694A EC SP003694 A ECSP003694 A EC SP003694A EC SP003694 A ECSP003694 A EC SP003694A
Authority
EC
Ecuador
Prior art keywords
treatment
amino
day
malaria
furanone
Prior art date
Application number
EC2000003694A
Other languages
English (en)
Inventor
Ramesh Chandra Gupta
Francis Joseph Pinto
Swati Ajay Piramal
Ram Pratap
Amiya Prasad Bhaduri
Harsh Pati Thapliyal
Sunil Kumar Puri
Guru Prasad Dutta
Anil Kumar Dwivedi
Satyawan Singh
Pratina Srivastava
Vikash Chandra Pandey
Sudhir Srivastava
Shio Kumar Singh
Jagdishwar Sahai Srivastava
Omkar Prasad Asthana
Original Assignee
Nicholas Piramal India Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nicholas Piramal India Ltd filed Critical Nicholas Piramal India Ltd
Publication of ECSP003694A publication Critical patent/ECSP003694A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/4706—4-Aminoquinolines; 8-Aminoquinolines, e.g. chloroquine, primaquine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A61P33/06—Antimalarials
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

Un estuche de combinación para el tratamiento del paludismo producido por Plasmodium vivax (p.vivax), que tiene dosis individuales de un agente antipalúdico, 3-[1-[[4-[(6-metoxi-8-quinolinil)amino]pentil}amino}etilideno]-dihidro-2-(3H)furanona (I) en forma de cápsulas; dosis individuales del agente antipalúdico cloroquina en forma de comprimidos; y material de instrucciones para la administración de los dos fármacos antipalúdicos. El estuche de combinación es particularmente adecuado para un régimen de tratamiento de 6 días, en el que el tratamiento se consigue mediante cinco comprimidos que contienen 500 mg de fosfato de cloroquinina (equivalentes a 300 mg de base), debiendo tomarse tres el d{ia uno y uno cada uno de los días dos y tres; y cinco cápsulas que contienen 25 mg de 3-[1-[[4-[(6-metoxi-8-quinolinil) amino]pentil]amino}etilideno]-dihidro-2(3H)furanona (I), debiendo tomarse una cada uno de los dias dos a seis.
EC2000003694A 2000-05-31 2000-10-05 Kit combinado para el tratamiento de la malaria ECSP003694A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IN501MU2000 2000-05-31

Publications (1)

Publication Number Publication Date
ECSP003694A true ECSP003694A (es) 2002-01-25

Family

ID=11097250

Family Applications (1)

Application Number Title Priority Date Filing Date
EC2000003694A ECSP003694A (es) 2000-05-31 2000-10-05 Kit combinado para el tratamiento de la malaria

Country Status (28)

Country Link
US (1) US7404962B1 (es)
EP (1) EP1292306B1 (es)
JP (1) JP2004505017A (es)
KR (1) KR20030025926A (es)
AP (1) AP1435A (es)
AR (1) AR028458A1 (es)
AT (1) ATE314848T1 (es)
AU (2) AU2879001A (es)
BR (1) BR0005247A (es)
CA (1) CA2413775C (es)
CR (1) CR6835A (es)
CZ (1) CZ296875B6 (es)
DE (2) DE00993875T1 (es)
DK (1) DK1292306T3 (es)
EC (1) ECSP003694A (es)
ES (1) ES2200729T3 (es)
GT (1) GT200000187A (es)
HK (1) HK1052467B (es)
HN (1) HN2001000118A (es)
HU (1) HUP0301925A3 (es)
MX (1) MXPA02011883A (es)
NO (1) NO324774B1 (es)
OA (1) OA12276A (es)
PE (1) PE20011319A1 (es)
PL (1) PL200748B1 (es)
SV (1) SV2002000201A (es)
WO (1) WO2001091535A2 (es)
ZA (1) ZA200209726B (es)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2007098047A2 (en) * 2006-02-16 2007-08-30 The Mclean Hospital Corporation Methods and compositions for the treatment of parkinson's disease
EP2379505A4 (en) * 2008-12-05 2012-10-17 Designmedix Inc MODIFIED CHLOROQUINE WITH SINGLE RING UNIT OR CONDENSED RING UNIT
WO2010144102A1 (en) * 2009-06-09 2010-12-16 The United States Of America, As Represented By The Secretary Of The Army, On Behalf Of U.S. Army Medical Research And Material Command Pentafluorosulfanyl analogs of mefloquine

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4431807A (en) * 1980-06-12 1984-02-14 The United States Of America As Represented By The Secretary Of The Army 4-Methyl-5-(unsubstituted and substituted phenoxy)-6-methoxy-8-(aminoalkylamino)quinolines
US5219865A (en) * 1987-05-08 1993-06-15 Hoechst Aktiengesellschaft Pharmaceutical combination for the prophylaxis and therapy of malaria
US5373005A (en) * 1988-04-20 1994-12-13 Merrell Dow Pharmaceuticals Inc. Despiramine in the treatment of drug-resistant malarial infections
US5270037A (en) * 1990-07-12 1993-12-14 Boehringer Ingelheim Gmbh Use of interferon and a substance with an antimalarial activity for the treatment of malaria infections
FI934360A0 (fi) * 1992-02-07 1993-10-04 Ciba Geigy Ag Synergistiska antimalariakompositioner innehaollande benflumetol

Also Published As

Publication number Publication date
AU2001228790B2 (en) 2007-02-01
AR028458A1 (es) 2003-05-07
PE20011319A1 (es) 2002-03-02
SV2002000201A (es) 2002-10-24
ZA200209726B (en) 2004-03-10
NO20025765L (no) 2003-01-08
HK1052467B (en) 2006-03-10
NO324774B1 (no) 2007-12-10
CZ20024071A3 (cs) 2003-04-16
WO2001091535A2 (en) 2001-12-06
ES2200729T1 (es) 2004-03-16
HUP0301925A3 (en) 2009-03-30
AU2879001A (en) 2001-12-11
PL372718A1 (en) 2005-07-25
DE60025403T2 (de) 2006-08-24
HK1052467A1 (en) 2003-09-19
CA2413775A1 (en) 2001-12-06
GT200000187A (es) 2002-04-18
CZ296875B6 (cs) 2006-07-12
DE60025403D1 (de) 2006-03-30
US7404962B1 (en) 2008-07-29
HUP0301925A2 (hu) 2003-09-29
PL200748B1 (pl) 2009-02-27
DK1292306T3 (da) 2006-05-22
OA12276A (en) 2006-05-10
KR20030025926A (ko) 2003-03-29
AP1435A (en) 2005-06-21
WO2001091535B1 (en) 2002-10-31
CR6835A (es) 2007-04-26
EP1292306A2 (en) 2003-03-19
BR0005247A (pt) 2002-02-13
MXPA02011883A (es) 2004-05-17
ES2200729T3 (es) 2006-07-16
AP2002002672A0 (en) 2002-12-31
EP1292306B1 (en) 2006-01-04
ATE314848T1 (de) 2006-02-15
HN2001000118A (es) 2001-10-29
WO2001091535A3 (en) 2002-07-04
DE00993875T1 (de) 2004-04-15
CA2413775C (en) 2009-08-25
NO20025765D0 (no) 2002-11-29
JP2004505017A (ja) 2004-02-19

Similar Documents

Publication Publication Date Title
BR0012869A (pt) Forma de dosagem farmacêutica de componentes múltiplos
AR035500A1 (es) Uso de clorpromazina y pentamidina para la fabricacion de medicamentos, composicion farmaceutica y paquete farmaceutico que comprenden clorpromazina y pentamidina.
AR025962A1 (es) Imidazo-3-il-aminas biciclicas, procedimiento para su preparacion y medicamentos que los contienen
AR057152A1 (es) Sistema terapeutico transdermico
ES2571703T3 (es) Formulaciones de oxicodona de una vez al día
AR040721A1 (es) Metodos y formas de dosificacion para l aliberacion controlada de paliperidona
AR037256A1 (es) Forma de dosificacion de liberacion controlada dual
ATE215816T1 (de) Feste oral anzuwendende arzeneiform
AR005282A1 (es) Composición farmacéutica oral en la forma de un comprimido de unidades múltiples, uso de la misma para la preparación de medicamnetos, y procedimiento para su manufactura.
CY1112361T1 (el) Σκευασματα για αντικαρκινικη θεραπεια που περιεχουν εκτεϊνασκιδινη 743
AR034813A1 (es) Composiciones farmaceuticas y uso de las mismas
UY26371A1 (es) Imidazo-3-il-aminas biciclicas, procedimiento para su preparacion y medicamentos que las contienen
CO5540294A2 (es) Una combinacion de un derivado de rapamicina y un agente alquilante seleccionado de ciclofosfamida y carmustina y composiciones que las contienen
ES2054333T3 (es) Forma de dosificacion para administrar un antagonista del calcio.
CO4920200A1 (es) Empaques farmaceuticos para ayudar o aumentar el cumplimien- to en la administracion de un regimen complejo de droga por via oral y metodos para su utilizacion
CO5200854A1 (es) Formulaciones farmaceuticas orales en capsulas de gelatina de hidroxipropilmetil celulosa que comprenden un derivado de camptotecina dentro de una matriz semisolida de polietilenglicol
PE20030830A1 (es) Ambroxol para el tratamiento de estados dolorosos en la cavidad bucal y faringea
AR022621A1 (es) Composicion farmaceutica que contiene desoxipeganina para el tratamiento de la dependencia de la nicotina
HN2001000118A (es) Un estuche de combinacion usado en el tratamiento de paludismo.
CO5271706A1 (es) Unidad de dosis de mirtazapina para el tratamiento de transtornos del sueno
ES2188513T3 (es) Utilizacion de desoxipeganina para el tratamiento de la drogodependencia.
TNSN05334A1 (en) A combination kit in the treatment of malaria
TNSN02095A1 (en) A combination kit used in the treatment of malaria
RU2005101874A (ru) Синергетическое взаимодействие абакавира и аловудина
ATE311883T1 (de) Stabile pharmazeutische anwendungsform für paroxetin-anhydrat